Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity
Current Obesity Reports · 01.06.2024 · 13 (3) · 626-641
DOI: 10.1007/s13679-024-00567-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Obesity Reports, online erschienen am 01.06.2024. Verfasst von Michael V Zuccaro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, United States. Hauptthemen laut MEDLINE: Genetic Testing, Genetic Therapy, Obesity, Genetic Predisposition to Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Pfizer's Centers for Therapeutic Innovation, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
PURPOSE OF REVIEW: The goal of this paper is to aggregate information on monogenic contributions to obesity in the past five years and to provide guidance for genetic testing in clinical care. RECENT FINDINGS: Advances in sequencing technologies, increasing awareness, access to testing, and new treatments have increased the utilization of genetics in clinical care. There is increasing recognition of the prevalence of rare genetic obesity from variants with mean allele frequency < 5% -new variants in known genes as well as identification of novel genes- causing monogenic obesity. While most of these genes are in the leptin melanocortin pathway, those in adipocytes may also contribute. Common variants may contribute either to higher lifetime tendency for weight gain or provide protection from monogenic obesity. While specific genetic mutations are rare, these segregate in individuals with early-onset severe obesity; thus, collectively genetic etiologies are not as rare. Some genetic conditions are amenable to targeted treatment. Research into the discovery of novel genetic causes as well as targeted treatment is growing over time. The utility of therapeutic strategies based on the genetic risk of obesity is an advancing frontier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, United States.
- Division of Molecular Genetics, Department of Pediatrics, Columbia University Irving Medical Center, 1150, St. Nicholas Avenue, NY 10032, United States.
- Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, United States.
- Division of Molecular Genetics, Department of Pediatrics, Columbia University Irving Medical Center, 1150, St. Nicholas Avenue, NY 10032, United States. vvt2114@cumc.columbia.edu.
- Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, United States. vvt2114@cumc.columbia.edu.
- Division of Pediatric Endocrinology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, 10032, United States. vvt2114@cumc.columbia.edu.
Förderung
- Pfizer's Centers for Therapeutic Innovation
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Pfizer’s Centers for Therapeutic Innovation
Zitieren
APA
Zuccaro, M. V., LeDuc, C. A., & Thaker, V. V. (2024). Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity. Current Obesity Reports, 13(3), 626-641. https://doi.org/10.1007/s13679-024-00567-y
Vancouver
Zuccaro MV, LeDuc CA, Thaker VV. Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity. Current Obesity Reports. 2024;13(3):626-641. doi:10.1007/s13679-024-00567-y
BibTeX
@article{Zuccaro2024,
author = {Zuccaro, Michael V and LeDuc, Charles A and Thaker, Vidhu V},
title = {Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity},
journal = {Current Obesity Reports},
year = {2024},
volume = {13},
number = {3},
pages = {626--641},
doi = {10.1007/s13679-024-00567-y}
}
EUVIMED